Newborn screening strategy needs modernising as HHS disbands advisory committee
After sweeping cuts to US federal health agencies, the elimination of a committee responsible for recommending newborn screening regulations is…
Features
Pharma’s AI prospects get nudged into the future with EU’s AI act
Are regulators keeping pace with AI adoption in clinical trials?
Introducing the Pharmaceutical Technology Excellence Awards 2025
Entering the era of prenatal gene therapies
Magazine: The GLP-1 shortage is over. What’s next for compounders?
Myostatin inhibitors target muscle loss prevention to fill gap in GLP-1RA market
FDA layoffs and priority review programme’s lapse disrupt rare disease pipeline
